Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?

Date

2014

Authors

Luk, F
Bebawy, Mary
Callaghan, Richard

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Pharmacology and Experimental Therapeutics

Abstract

P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The protein confers resistance by mediating the ATP-dependent efflux of an astonishing array of anticancer drugs. Its broad specificity has been the subject of numerous

Description

Keywords

Citation

Source

Drug Metabolism and Disposition

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31